We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Infectious Diseases

Rotavirus Vaccine Significantly Reduces Mortality from Rotavirus-Associated Acute Gastroenteritis in Children Under 5: Insights from the MNSSTER-V Global Dataset

MedXY Editorial Team•Aug 20, 2026•Infectious Diseases
Rotavirus vaccine急性胃肠炎Child mortalityvaccine effectiveness

Highlight

This large pooled case-control study from the Multi-National Subpopulations Study to Evaluate Rotavirus Vaccines (MNSSTER-V) dataset shows that rotavirus vaccination provides 75.8% effectiveness against rotavirus-positive acute gastroenteritis mortality in children under five. Despite a smaller, non-significant reduction against all-cause acute gastroenteritis deaths, these findings highlight the critical importance of rotavirus vaccines in global child health. Continuous efforts to improve vaccine coverage could substantially reduce diarrhoeal deaths worldwide.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes: A Comprehensive ReviewThis review synthesizes emerging evidence demonstrating robust effectiveness of RSV vaccination in reducing hospitalization, death, and severe outcomes among elderly nursing home residents during the vaccine’s inaugural season.Sep 11, 2026Rotavirus Vaccination and Type 1 Diabetes Incidence: Insights from a Norwegian Population-Based Natural ExperimentNorwegian cohort data reveal no protective effect of rotavirus vaccination against type 1 diabetes onset in early childhood, clarifying prior conflicting findings.Aug 29, 2026Impact of Emergency Department Pediatric Readiness and Inpatient Services on Child Mortality: A Decade-Long Cohort StudyThis cohort study links changes in emergency department pediatric readiness and inpatient pediatric services over ten years with excess child mortality, highlighting the critical role of hospital preparedness in pediatric survival.Aug 20, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Estimated Effectiveness of 2024-2025 COVID-19 Vaccines in Adults: A Comprehensive Review of Recent Evidence
This review synthesizes recent evidence on the effectiveness of 2024-2025 COVID-19 vaccines in adults, highlighting moderate protection against symptomatic illness, hospitalization, and critical outcomes, with emphasis on waning immunity an
Aug 7, 2026
Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-Related Hospitalization Among US Adults Aged ≥60 Years: A Comprehensive ReviewThis review synthesizes current evidence on the effectiveness of adjuvanted RSVPreF3 vaccination in reducing RSV-related hospitalizations among older US adults, highlighting substantial protection across high-risk subgroups.Jul 20, 2026
Optimizing Influenza Protection in Older Adults with Diabetes: Insights from the DANFLU-2 TrialA secondary analysis of the DANFLU-2 trial confirms that high-dose influenza vaccine significantly reduces cardiorespiratory hospitalizations in older adults with diabetes, with potentially enhanced benefits for those with longer disease duMar 18, 2026